The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Pharmacology of anabolic steroids
Open accessAbstract
Athletes and bodybuilders have recognized for several decades that the use of anabolic steroids can promote muscle growth and strength but it is only relatively recently that these agents are being revisited for clinical purposes. Anabolic steroids are being considered for the treatment of cachexia associated with chronic disease states, and to address loss of muscle mass in the elderly, but nevertheless their efficacy still needs to be demonstrated in terms of improved physical function and quality of life. In sport, these agents are performance enhancers, this being particularly apparent in women, although there is a high risk of virilization despite the favourable myotrophic–androgenic dissociation that many xenobiotic steroids confer. Modulation of androgen receptor expression appears to be key to partial dissociation, with consideration of both intracellular steroid metabolism and the topology of the bound androgen receptor interacting with co‐activators. An anticatabolic effect, by interfering with glucocorticoid receptor expression, remains an attractive hypothesis. Behavioural changes by non‐genomic and genomic pathways probably help motivate training. Anabolic steroids continue to be the most common adverse finding in sport and, although apparently rare, designer steroids have been synthesized in an attempt to circumvent the dope test. Doping with anabolic steroids can result in damage to health, as recorded meticulously in the former German Democratic Republic. Even so, it is important not to exaggerate the medical risks associated with their administration for sporting or bodybuilding purposes but to emphasize to users that an attitude of personal invulnerability to their adverse effects is certainly misguided. British Journal of Pharmacology(2008)154, 502–521; doi:fn1
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Steroid 5α-reductase: two genes/two enzymes
Russell, D. W., & Wilson, J. D. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.000325 · Cited by 1,105
Biological Actions of Androgens
MOORADIAN, A. D., MORLEY, J. E., & KORENMAN, S. G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-1-1 · Cited by 1,080
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 3×
“…doubling of the serum total and free concentrations of testosterone from the baseline values in eugonadal men over a 20-week period caused significant increases in strength and power (see the results reported by Bhasin et al. (2001), regarding the weekly regimen of 300 mg testosterone enanthate).”
BackgroundAndrogen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.
Thigpen, A. E., Silver, R. I., Guileyardo, J. M., Casey, M. L., McConnell, J. D., & Russell, D. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116665 · Cited by 727
Handbook of Experimental Pharmacology
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-1-269_2 · Cited by 727
Pope, H. G. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950050035004 · Cited by 604
The Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions
Heinlein, C. A., & Chang, C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0070 · Cited by 568
Nongenomic steroid action: controversies, questions, and answers
LÖSEL, R. M., FALKENSTEIN, E., FEURING, M., SCHULTZ, A., TILLMANN, H.-C., ROSSOL-HASEROTH, K., & WEHLING, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00003.2003 · Cited by 561
Controlling nuclear receptors: the circular logic of cofactor cycles
Perissi, V., & Rosenfeld, M. G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1680 · Cited by 510
Clark, R. V., Hermann, D. J., Cunningham, G. R., Wilson, T. H., Morrill, B. B., & Hobbs, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030330 · Cited by 467
Franke, W. W., & Berendonk, B. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.7.1262 · Cited by 457
Anabolic steroids: A review of the literature
Haupt, H. A., & Rovere, G. D. (1984) · The American Journal of Sports Medicine · doi:10.1177/036354658401200613 · Cited by 444
Shahidi, N. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80114-4 · Cited by 429
WILSON, J. D. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-2-181 · Cited by 427
Horton, R., & Tait, J. F. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105344 · Cited by 401
Hershberger, L. G., Shipley, E. G., & Meyer, R. K. (1953) · Experimental Biology and Medicine · doi:10.3181/00379727-83-20301 · Cited by 384
Johansen, K. L., Painter, P. L., Sakkas, G. K., Gordon, P., Doyle, J., & Shubert, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010034 · Cited by 380
Metabolism of anabolic androgenic steroids
Schänzer, W. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.7.1001 · Cited by 372
Rapid Actions of Steroid Receptors in Cellular Signaling Pathways
Cato, A. C. B., Nestl, A., & Mink, S. (2002) · Science's STKE · doi:10.1126/stke.2002.138.re9 · Cited by 369
Anabolic-Androgenic Steroid Use in the United States
Yesalis, C. E. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510100067034 · Cited by 331
FHL2, a novel tissue-specific coactivator of the androgen receptor
Muller, J. M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.359 · Cited by 326
Bardin, C. W., & Lipsett, M. B. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105588 · Cited by 322
Wärnmark, A., Treuter, E., Wright, A. P. H., & Gustafsson, J.-A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0384 · Cited by 308
Olsen, E. A., Hordinsky, M., Whiting, D., Stough, D., Hobbs, S., Ellis, M. L., Wilson, T., & Rittmaster, R. S. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.007 · Cited by 303
Bhasin, S., Calof, O. M., Storer, T. W., Lee, M. L., Mazer, N. A., Jasuja, R., Montori, V. M., Gao, W., & Dalton, J. T. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0120 · Cited by 300
Negro-Vilar, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3459 · Cited by 282
Johansen, K. L., Mulligan, K., & Schambelan, M. (1999) · JAMA · doi:10.1001/jama.281.14.1275 · Cited by 275
Tetrahydrogestrinone: discovery, synthesis, and detection in urine
Catlin, D. H., Sekera, M. H., Ahrens, B. D., Starcevic, B., Chang, Y., & Hatton, C. K. (2004) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1495 · Cited by 260
GLOYNA, R. E., & WILSON, J. D. (1969) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-29-7-970 · Cited by 257
Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases
Basaria, S., Wahlstrom, J. T., & Dobs, A. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.7983 · Cited by 234
Behavioral and physiological responses to anabolic-androgenic steroids
Clark, A. S., & Henderson, L. P. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00064-2 · Cited by 231
Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases
Basaria, S. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.11.5108 · Cited by 223
Thiboutot, D., Harris, G., Iles, V., Cimis, G., Gilliland, K., & Hagari, S. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12317162 · Cited by 221
SAARTOK, T., DAHLBERG, E., & GUSTAFSSON, J.-Å. (1984) · Endocrinology · doi:10.1210/endo-114-6-2100 · Cited by 215
Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)
Gao, W., & Dalton, J. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.01.003 · Cited by 215
Steroid Receptor Phosphorylation: A Key Modulator of Multiple Receptor Functions
Weigel, N. L., & Moore, N. L. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0101 · Cited by 196
Chaperoning steroid hormone action
Picard, D. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.06.003 · Cited by 189
Steroids. LIV.1 Synthesis of 19-Nov-17α-ethynyltestosterone and 19-Nor-17α-methyltestosterone2
Djerassi, C., Miramontes, L., Rosenkranz, G., & Sondheimer, F. (1954) · Journal of the American Chemical Society · doi:10.1021/ja01645a010 · Cited by 172
Kuhn, C. M. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.411 · Cited by 168
Medical issues associated with anabolic steroid use: are they exaggerated?
Hoffman, J. R., & Ratamess, N. A. (2006) · Europe PMC (PubMed Central) · Cited by 157
Anabolic steroids in sport: biochemical, clinical and analytical perspectives
Kicman, A. T., & Gower, D. B. (2003) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456303766476977 · Cited by 147
Self-citationAnother designer steroid: discovery, synthesis, and detection of ‘madol’ in urine
Sekera, M. H., Ahrens, B. D., Chang, Y., Starcevic, B., Georgakopoulos, C. G., & Catlin, D. H. (2005) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1858 · Cited by 144
Indications of prevalence, practice and effects of anabolic steroid use in Great Britain.
Korkia, P., & Stimson, G. (1997) · International Journal of Sports Medicine · doi:10.1055/s-2007-972681 · Cited by 143
9 Role of 5α-reductase in health and disease
Randall, V. A. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80259-9 · Cited by 140
Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine
Catlin, D. H., Ahrens, B. D., & Kucherova, Y. (2002) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.722 · Cited by 136
Metabolism and excretion of anabolic steroids in doping control—New steroids and new insights
Eenoo, P. V., & Delbeke, F. T. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.06.024 · Cited by 135
Thevis, M., Geyer, H., Mareck, U., & Schänzer, W. (2005) · Journal of Mass Spectrometry · doi:10.1002/jms.873 · Cited by 134
THE LEVATOR ANI MUSCLE OF THE RAT AS AN INDEX OF MYOTROPHIC ACTIVITY OF STEROIDAL HORMONES
Eisenberg, E. J., & Gordan, G. S. (1950) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)04222-3 · Cited by 133
Androgen Receptor: Structural Domains and Functional Dynamics after Ligand‐Receptor Interaction
Roy, A. K., Tyagi, R. K., Song, C. S., Lavrovsky, Y., Ahn, S., Oh, T., & Chatterjee, B. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb04001.x · Cited by 132
Nielen, M. W. F., Bovee, T. F. H., van Engelen, M. C., Rutgers, P., Hamers, A. R. M., van Rhijn, J. A., & Hoogenboom, L. A. P. (2005) · Analytical Chemistry · doi:10.1021/ac051317q · Cited by 130
Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man
Horst, H.-J., H�ltje, W. J., Dennis, M. J., Coert, A., Geelen, J., & Voigt, K. D. (1976) · Journal of Molecular Medicine · doi:10.1007/bf01483589 · Cited by 128
Trends in Anabolic-Androgenic Steroid Use Among Adolescents
Yesalis, C. E. (1997) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1997.02170490023005 · Cited by 127
Cellotti, F., & Negri‐Cesi, P. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90085-w · Cited by 122
An overview of the endocrinology of skeletal muscle
Sheffield‐Moore, M., & Urban, R. J. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.02.009 · Cited by 121
Illicit anabolic steroid use in athletes: A case series analysis
Perry, P. J., Andersen, K. H., & Yates, W. R. (1990) · The American Journal of Sports Medicine · doi:10.1177/036354659001800416 · Cited by 113
Androgen Receptor in Rat Skeletal Muscle:Characterization and Physiological Variations*
MICHEL, G., & Baulieu, É.-É. (1980) · Endocrinology · doi:10.1210/endo-107-6-2088 · Cited by 112
Kumar, N., Didolkar, A. K., Monder, C., Bardin, C. W., & Sundaram, K. (1992) · Endocrinology · doi:10.1210/endo.130.6.1597164 · Cited by 104
Effects of castration and androgen treatment on androgen-receptor levels in rat skeletal muscles
António, J., Wilson, J. D., & George, F. W. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.87.6.2016 · Cited by 104
THE PHARMACOLOGY AND METABOLISM OF TESTOSTERONE UNDECANOATE (TU), A NEW ORALLY ACTIVE ANDROGEN
Coert, A., Geelen, J., de Visser, J., & van der Vies, J. (1975) · European Journal of Endocrinology · doi:10.1530/acta.0.0790789 · Cited by 99
Behavioural effects of androgen in men and women
Christiansen, K. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1700039 · Cited by 97
Glucocorticoid antagonism by exercise and androgenic-anabolic steroids
Hickson, R. C., Czerwinski, S. M., Falduto, M. T., & Young, A. P. (1990) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199006000-00010 · Cited by 94
Tetrahydrogestrinone Is a Potent Androgen and Progestin
Death, A. K., McGrath, K. C. Y., Kazlauskas, R., & Handelsman, D. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0033 · Cited by 93
Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men
Brown, G. A., Vukovich, M. D., Sharp, R. L., Reifenrath, T. A., Parsons, K. A., & King, D. S. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.87.6.2274 · Cited by 92
Anabolic Steroids in the Athlete
Strauss, R. H., & Yesalis, C. E. (1991) · Annual Review of Medicine · doi:10.1146/annurev.me.42.020191.002313 · Cited by 92
Regulation of the Androgen and Glucocorticoid Receptors in Rat and Mouse Skeletal Muscle Cytosol*
Dahlberg, E., Snochowski, M., & Gustafsson, J.-Α. (1981) · Endocrinology · doi:10.1210/endo-108-4-1431 · Cited by 89
Landry, G. L., & Primos, W. A. (1990) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00243-3 · Cited by 87
The Role of Gonadal Steroids in Sexual Differentiation
Wilson, J. D., Griffin, J. E., George, F. W., & Leshin, M. (1981) · Elsevier eBooks · doi:10.1016/b978-0-12-571137-1.50006-2 · Cited by 85
Doping among Adolescent Athletes
Yesalis, C. E., & Bahrke, M. S. (2000) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2000.0051 · Cited by 81
Tóth, M., & Zakár, T. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90567-2 · Cited by 76
Woodhouse, L. J., Reisz-Porszasz, S., Javanbakht, M., Storer, T. W., Lee, M., Zerounian, H., & Bhasin, S. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00536.2002 · Cited by 73
Modulation of the Cytosolic Androgen Receptor in Striated Muscle by Sex Steroids*
Rance, N. E., & Max, S. R. (1984) · Endocrinology · doi:10.1210/endo-115-3-862 · Cited by 64
Androgen Therapy Induces Muscle Protein Anabolism in Older Women
Sheffield‐Moore, M., Paddon‐Jones, D., Casperson, S. L., Gilkison, C. R., Volpi, E., Wolf, S. E., Jiang, J., Rosenblatt, J. I., & Urban, R. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0588 · Cited by 61
Larionov, A. A., Vasyliev, D. A., Mason, J. I., Howie, A. F., Berstein, L. M., & Miller, W. R. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00059-1 · Cited by 58
Clinical review 31: Anabolic-androgenic steroids and athletes: what are the issues?
Rogol, A. D., & Yesalis, C. E. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1740476 · Cited by 55
Aromatization of 7α-Methyl-19-nortestosterone by human placental microsomes in vitro
LaMorte, A., Kumar, N., Bardin, C. W., & Sundaram, K. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90160-0 · Cited by 54
Androgens as anabolic agents for bone
ORWOLL, E. S. (1996) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(96)00024-0 · Cited by 53
Steroid 5-alpha Reductase: Two Genes/Two Enzymes
Russell, D. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.63.1.25 · Cited by 53
Klötz, F., Petersson, A. M., Isacson, D. G. L., & Thiblin, I. (2007) · Forensic Science International · doi:10.1016/j.forsciint.2007.01.026 · Cited by 52
Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid
Labrie, F., Luu-The, V., Calvo, E. L., Martel, C., Cloutier, J., Gauthier, S., Belleau, P., Morissette, J., Lévesque, M.-H., & Labrie, C. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05997 · Cited by 50
Holterhus, P., Piefke, S., & Hiort, O. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00220-0 · Cited by 49
A systemic type i 5 α-reductase inhibitor is ineffective in the treatment of acne vulgaris
Leyden, J., Bergfeld, W., Drake, L., Dunlap, F., Goldman, M. P., Gottlieb, A. B., Heffernan, M. P., Hickman, J. G., Hordinsky, M., Jarrett, M., et al. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.07.021 · Cited by 48
BARTSCH, W., Krieg, M., & Voigt, K. (1980) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(80)90003-5 · Cited by 48
Testosterone Prohormone Supplements
Brown, G. A., Vukovich, M. D., & King, D. S. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000228928.69512.2e · Cited by 46
Gao, W., & Dalton, J. T. (2007) · Molecular Interventions · doi:10.1124/mi.7.1.3 · Cited by 44
Tincello, D. G., Saunders, P. T. K., Hodgins, M. B., et al. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1140927.x · Cited by 37
In VitroMetabolism of 7α-Methyl-19-Nortestosterone by Rat Liver, Prostate, and Epididymis*
Agarwal, A. K., & Monder, C. (1988) · Endocrinology · doi:10.1210/endo-123-5-2187 · Cited by 37
Anabolic steroids for the treatment of weight loss in HIV-infected individuals.
Johns, K. K., Beddall, M., & Corrin, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005483 · Cited by 37
Sato, K., Sonoda, Itami, & Takayasu (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02504.x · Cited by 36
Finkelstein, J. S. (1998) · Springer eBooks · doi:10.1007/978-3-642-72185-4_6 · Cited by 35
Recent Developments in the Toxicology of Anabolic Steroids
Graham, S., & Kennedy, M. (1990) · Drug Safety · doi:10.2165/00002018-199005060-00007 · Cited by 33
Jasuja, R., Catlin, D. H., Miller, A., Chang, Y., Herbst, K. L., Starcevic, B., Artaza, J. N., Singh, R., Datta, G. D., Sarkissian, A., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0448 · Cited by 31
Leder, B. Z., Leblanc, K. M., Longcope, C., Lee, H., Catlin, D. H., & Finkelstein, J. S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021035 · Cited by 30
Kicman, A. T., Bassindale, T., Cowan, D., Dale, S., Hutt, A. J., & Leeds, A. (2003) · Clinical Chemistry · doi:10.1373/49.1.167 · Cited by 30
Self-citationFoxG1, a member of the forkhead family, is a corepressor of the androgen receptor
Obendorf, M., Meyer, R., Henning, K., Mitev, Y. A., Schröder, J., Patchev, V. K., & Wolf, S. S. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.03.012 · Cited by 29
Interaction between the androgen receptor and a segment of its corepressor SHP
Jouravel, N., Sablin, E. P., Arnold, L. A., Guy, R. K., & Fletterick, R. J. (2007) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444907045702 · Cited by 25
Anabolic steroids for the treatment of weight loss in HIV-infected individuals
Johns, K., Beddall, M., & Corrin, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002836.pub2 · Cited by 24
Feldkoren, B., & Andersson, S. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.036 · Cited by 22
Medical aspects of drug use in the gym
Kicman, A. T. (2004) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2004.4211 · Cited by 18
Self-citationBrown, G. A., Dewey, J. C., Brunkhorst, J. A., Vukovich, M. D., & King, D. S. (2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-814201 · Cited by 17
Anabolic-androgenic steroid-induced mental status changes.
Katz, D. L., & Hg, P. (1990) · PubMed · Cited by 16
Bassindale, T., Cowan, D., Dale, S., Hutt, A. J., Leeds, A., Wheeler, M. J., & Kicman, A. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0790 · Cited by 12
Self-citationThe androgen receptor: molecular biology
Klocker, H., Gromoll, J., & Cato, A. C. B. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545221.003 · Cited by 12
Cited by
British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE
Bolton, C. E., Bevan-Smith, E. F., Blakey, J. D., Crowe, P., Elkin, S. L., Garrod, R., Greening, N. J., Heslop, K., Hull, J. H., Man, W. D.-C., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203808 · Cited by 717
Pope, H. G., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1058 · Cited by 658
Adverse health effects of anabolic–androgenic steroids
van Amsterdam, J., Opperhuizen, A., & Hartgens, F. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2010.02.001 · Cited by 286
Designer drugs: mechanism of action and adverse effects
Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262
Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review
Albano, G. D., Amico, F., Cocimano, G., Liberto, A., Maglietta, F., Esposito, M., Rosi, G. L., Di Nunno, N., Salerno, M., & Montana, A. (2021) · Healthcare · doi:10.3390/healthcare9010097 · Cited by 200
Metadata
- Authors
- Kicman, A. T.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-06
- Volume
- 154
- Issue
- 3
- Pages
- 502-521
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2146145065
- Cited by
- 580
- References
- 105
- FWCI
- 17.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.